Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive human cancers. Several studies have reported that the carbohydrate antigen 19-9 (CA19-9) level is a useful marker for predicting the prognosis for PDAC after resection. However, the cutoff value of CA19-9 used to predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Qian, Yang, Xiang-hong, Zhang, Yao, Jing, Wei, Zheng, Li-qiang, Liu, Yun-peng, Qu, Xiu-juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064278/
https://www.ncbi.nlm.nih.gov/pubmed/24890327
http://dx.doi.org/10.1186/1477-7819-12-171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064278/
https://www.ncbi.nlm.nih.gov/pubmed/24890327
http://dx.doi.org/10.1186/1477-7819-12-171

Ejemplares similares